retatrutide triple agonist obesity trial Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Retatrutide—A Game Changer in Obesity

At Horizon, we pride ourselves on our comprehensive approach to help patients lose weight safely and maintain their weight loss long term

4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes

But Wegovy is prescribed for weight loss and weight management, and reducing alcohol consumption can help support weight loss

For many patients, the challenge is not just the number on the scale it is the cycle of fatigue, reduced activity, fluid retention, and discouragement that can make healthy habits feel less effective, which is why treating thyroid disease well and considering additional weight-loss support when appropriate can both matter